FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891800411> ?p ?o ?g. }

• W2891800411 endingPage "81" @default.
• W2891800411 startingPage "71" @default.
• W2891800411 abstract "Cutaneous immunoglobulin (Ig) amyloid light-chain (AL) amyloidosis associated with overt multiple myeloma (MM) is rare and optimal treatment is not well defined. The recently developed highly efficacious MM therapy has brought on a new set of challenges to this field for consideration. The goal of this paper is to describe the characteristics of cutaneous manifestations of systemic AL amyloidosis associated with MM according to age, sex, race, Ig type, plasma cell percentage, and cytogenetic and fluorescent in situ hybridization studies along with their outcomes. An electronic search of the PubMed database was performed to obtain key literature in AL amyloidosis and MM, using the following search terms: multiple myeloma, immunoglobulin light chain amyloidosis, and cutaneous amyloidosis. The search results were narrowed by selecting studies in English. Results were confined to the following articles types: case reports, case series, and systematic reviews. We identified 32 cases from the PubMed database search and examined their potential relevance. We found the following: (a) higher prevalence in women (two-thirds) and white population; (b) IgG and IgA were equally distributed with lambda (λ) light chain occurring in 53–66% of cases; (c) majority of cases (56%) presented as hemorrhagic bullous lesions, followed by purpura/ecchymosis in 25% of cases; and (d) majority (64%) died within 6 months since diagnosis. We reviewed the constellation of the cutaneous manifestations of AL amyloidosis with concurrent MM. We found a female predominance, and more than half presented as hemorrhagic bullous lesions. There is a preponderance of λ light chains over kappa (κ) light chains, both as a free light chain (15% vs. 4%) and as an intact Ig (38% vs. 24%; absolute number of 14 vs. 7 patients, respectively). In the subgroup of patients with bullous skin lesions, λ light chain was present in eight cases and κ light chain in seven cases. All κ light chain subtypes presented with bullous lesions and no other cutaneous types of lesions. They carried very poor prognosis with majority of cases surviving only 6 months, much worse than overall patients with AL amyloidosis without myeloma or myeloma without amyloidosis." @default.
• W2891800411 created "2018-09-27" @default.
• W2891800411 creator A5009218109 @default.
• W2891800411 creator A5040825280 @default.
• W2891800411 date "2019-06-01" @default.
• W2891800411 modified "2023-10-09" @default.
• W2891800411 title "Cutaneous light chain amyloidosis with multiple myeloma: A concise review" @default.
• W2891800411 cites W1487900963 @default.
• W2891800411 cites W1847028711 @default.
• W2891800411 cites W1969214107 @default.
• W2891800411 cites W1985493736 @default.
• W2891800411 cites W1992682070 @default.
• W2891800411 cites W1994746211 @default.
• W2891800411 cites W1999473831 @default.
• W2891800411 cites W2001594121 @default.
• W2891800411 cites W2009293121 @default.
• W2891800411 cites W2013938064 @default.
• W2891800411 cites W2014746170 @default.
• W2891800411 cites W2022686417 @default.
• W2891800411 cites W2027380684 @default.
• W2891800411 cites W2028883211 @default.
• W2891800411 cites W2033793452 @default.
• W2891800411 cites W2042367312 @default.
• W2891800411 cites W2051463882 @default.
• W2891800411 cites W2054440231 @default.
• W2891800411 cites W2059384194 @default.
• W2891800411 cites W2061316631 @default.
• W2891800411 cites W2066309257 @default.
• W2891800411 cites W2074136477 @default.
• W2891800411 cites W2079622451 @default.
• W2891800411 cites W2085951028 @default.
• W2891800411 cites W2091692010 @default.
• W2891800411 cites W2097239715 @default.
• W2891800411 cites W2106512137 @default.
• W2891800411 cites W2108020531 @default.
• W2891800411 cites W2110940551 @default.
• W2891800411 cites W2111059976 @default.
• W2891800411 cites W2154463920 @default.
• W2891800411 cites W2161746090 @default.
• W2891800411 cites W2165673370 @default.
• W2891800411 cites W2194865217 @default.
• W2891800411 cites W2288672738 @default.
• W2891800411 cites W2288834768 @default.
• W2891800411 cites W2332241363 @default.
• W2891800411 cites W2549380959 @default.
• W2891800411 cites W2555124885 @default.
• W2891800411 cites W2564961855 @default.
• W2891800411 cites W2587934256 @default.
• W2891800411 cites W2598245499 @default.
• W2891800411 cites W4234404151 @default.
• W2891800411 cites W4241231688 @default.
• W2891800411 cites W4243244645 @default.
• W2891800411 cites W4246058483 @default.
• W2891800411 cites W4246404253 @default.
• W2891800411 cites W4248008724 @default.
• W2891800411 doi "https://doi.org/10.1016/j.hemonc.2018.09.003" @default.
• W2891800411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30261180" @default.
• W2891800411 hasPublicationYear "2019" @default.
• W2891800411 type Work @default.
• W2891800411 sameAs 2891800411 @default.
• W2891800411 citedByCount "20" @default.
• W2891800411 countsByYear W28918004112019 @default.
• W2891800411 countsByYear W28918004112020 @default.
• W2891800411 countsByYear W28918004112021 @default.
• W2891800411 countsByYear W28918004112022 @default.
• W2891800411 countsByYear W28918004112023 @default.
• W2891800411 crossrefType "journal-article" @default.
• W2891800411 hasAuthorship W2891800411A5009218109 @default.
• W2891800411 hasAuthorship W2891800411A5040825280 @default.
• W2891800411 hasBestOaLocation W28918004111 @default.
• W2891800411 hasConcept C126322002 @default.
• W2891800411 hasConcept C142724271 @default.
• W2891800411 hasConcept C159654299 @default.
• W2891800411 hasConcept C16005928 @default.
• W2891800411 hasConcept C203014093 @default.
• W2891800411 hasConcept C2776364478 @default.
• W2891800411 hasConcept C2779551797 @default.
• W2891800411 hasConcept C2779663748 @default.
• W2891800411 hasConcept C2779951007 @default.
• W2891800411 hasConcept C2908647359 @default.
• W2891800411 hasConcept C36394416 @default.
• W2891800411 hasConcept C71924100 @default.
• W2891800411 hasConcept C99454951 @default.
• W2891800411 hasConceptScore W2891800411C126322002 @default.
• W2891800411 hasConceptScore W2891800411C142724271 @default.
• W2891800411 hasConceptScore W2891800411C159654299 @default.
• W2891800411 hasConceptScore W2891800411C16005928 @default.
• W2891800411 hasConceptScore W2891800411C203014093 @default.
• W2891800411 hasConceptScore W2891800411C2776364478 @default.
• W2891800411 hasConceptScore W2891800411C2779551797 @default.
• W2891800411 hasConceptScore W2891800411C2779663748 @default.
• W2891800411 hasConceptScore W2891800411C2779951007 @default.
• W2891800411 hasConceptScore W2891800411C2908647359 @default.
• W2891800411 hasConceptScore W2891800411C36394416 @default.
• W2891800411 hasConceptScore W2891800411C71924100 @default.
• W2891800411 hasConceptScore W2891800411C99454951 @default.
• W2891800411 hasIssue "2" @default.
• W2891800411 hasLocation W28918004111 @default.

• next